Analysis of Y-P30/Dermcidin expression and properties of the Y-P30 peptide
Autor: | Mikhaylova, Marina, Schumacher, A., Borutzki, C., Neumann, J.R., Macharadze, T., El-Mousleh, T., Wahle, P., Zenclussen, A.C., Kreutz, M.R., Sub Cell Biology, Celbiologie |
---|---|
Přispěvatelé: | Sub Cell Biology, Celbiologie |
Jazyk: | angličtina |
Rok vydání: | 2014 |
Předmět: |
animal diseases
viruses Placenta Gene Expression Peptide Pregnancy Chlorocebus aethiops Cells Cultured Progesterone Medicine(all) chemistry.chemical_classification Microscopy Confocal Estradiol Reverse Transcriptase Polymerase Chain Reaction General Medicine Transfection medicine.anatomical_structure COS Cells Female alpha-Fetoproteins Research Article Adult Syndecans Blotting Western Green Fluorescent Proteins Biology Peripheral blood mononuclear cell General Biochemistry Genetics and Molecular Biology Young Adult Immune system parasitic diseases medicine Dermcidin Y-P30 Animals Humans Secretion Biochemistry Genetics and Molecular Biology(all) urogenital system HEK 293 cells Molecular biology In vitro Pregnancy Trimester First HEK293 Cells chemistry PBMCs Leukocytes Mononuclear Syndecan-3 Syndecan-4 Peptides |
Zdroj: | BMC Research Notes BMC Research Notes, 7. BioMed Central |
ISSN: | 1756-0500 |
DOI: | 10.1186/1756-0500-7-400 |
Popis: | Background: The survival promoting peptide Y-P30 has a variety of neuritogenic and neuroprotective effects in vitro and in vivo. In previous work we reported the expression of Y-P30/dermcidin in maternal peripheral blood mononuclear cells (PBMCs) and the transport of the protein to the fetal brain. In this study we analyzed hormonal regulation of Y-P30 in human immune cells and expression of Y-P30 in the placenta. We further studied the stability and secretion of the Y-P30 peptide. Results: We found indications that Y-P30 might be produced in human placenta. The Y-P30 mRNA was rarely found in isolated human PBMCs and alpha-feto-protein, human chorionic gonadotropin as well as estradiol combined with progesterone could not induce Y-P30 expression. Y-P30 was found to be extraordinarily stable; therefore, contamination with the peptide and the Y-P30/Dermcidin precursor mRNA is a serious concern in experiments looking at the expression of Y-P30/Dermcidin. In cultured cell lines and primary neurons we found that Y-P30 could be released, but neuronal uptake of Y-P30 was not observed. Conclusions: Our data suggest that a source of Y-P30 apart from eccrine glands might be the placenta. The peptide can be secreted together with the signaling peptide and it might reach the fetal brain where it can exert its neuritogenic functions by binding to neuronal membranes. |
Databáze: | OpenAIRE |
Externí odkaz: |